| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |